Cargando…
Toxoplasma gondii induced cognitive impairment in rats via dysregulation of dopamine receptors and indoleamine 2,3 dioxygenase
Toxoplasma gondii (T. gondii) is a parasite capable of residing in the brain of their host which influences behaviour changes due to alterations in the neurotransmitters. Consequently, dopamine receptors (DRD) and indoleamine 2, 3 dioxygenase (IDO) dysregulation facilitate the progression of behavio...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025920/ https://www.ncbi.nlm.nih.gov/pubmed/36950587 http://dx.doi.org/10.1016/j.heliyon.2023.e14370 |
_version_ | 1784909437433020416 |
---|---|
author | Wana, Mohammed Nasiru Watanabe, Malaika Chiroma, Samaila Musa Unyah, Ngah Zasmy Abdullahi, Sharif Alhassan Nordin, Shariza Basir, Rusliza Mohd Moklas, Mohamad Aris Majid, Roslaini Abd |
author_facet | Wana, Mohammed Nasiru Watanabe, Malaika Chiroma, Samaila Musa Unyah, Ngah Zasmy Abdullahi, Sharif Alhassan Nordin, Shariza Basir, Rusliza Mohd Moklas, Mohamad Aris Majid, Roslaini Abd |
author_sort | Wana, Mohammed Nasiru |
collection | PubMed |
description | Toxoplasma gondii (T. gondii) is a parasite capable of residing in the brain of their host which influences behaviour changes due to alterations in the neurotransmitters. Consequently, dopamine receptors (DRD) and indoleamine 2, 3 dioxygenase (IDO) dysregulation facilitate the progression of behaviour changes in a host as a response to infection. This study tested the effect of neurotransmitter changes as a result of T. gondii infection on rats cognitive impairment. The T. gondii strain of type I, II and III from Malaysia were previously identified by standard procedures. Sporulated oocysts each of type I, II and III were inoculated separately into three groups of Wistar rats (n = 9) respectively. Two separate control groups received either phosphate buffered saline (PBS) or MK-801 (dizocilpine). Behaviour changes were evaluated at nine weeks post infection in a square box, elevated plus maze and gene expression level of DRD and IDO compounds. The study revealed increased fatal feline attraction, reduced anxiety, decreased DRD and increased IDO gene expression in the T. gondii infected groups and MK-801 compared to the PBS control group. In conclusion, T. gondii infection alter the level of neurotransmitters in rat which cause cognitive impairment. This implies that all the T. gondii strain can cause behaviour changes if human were infected. |
format | Online Article Text |
id | pubmed-10025920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-100259202023-03-21 Toxoplasma gondii induced cognitive impairment in rats via dysregulation of dopamine receptors and indoleamine 2,3 dioxygenase Wana, Mohammed Nasiru Watanabe, Malaika Chiroma, Samaila Musa Unyah, Ngah Zasmy Abdullahi, Sharif Alhassan Nordin, Shariza Basir, Rusliza Mohd Moklas, Mohamad Aris Majid, Roslaini Abd Heliyon Research Article Toxoplasma gondii (T. gondii) is a parasite capable of residing in the brain of their host which influences behaviour changes due to alterations in the neurotransmitters. Consequently, dopamine receptors (DRD) and indoleamine 2, 3 dioxygenase (IDO) dysregulation facilitate the progression of behaviour changes in a host as a response to infection. This study tested the effect of neurotransmitter changes as a result of T. gondii infection on rats cognitive impairment. The T. gondii strain of type I, II and III from Malaysia were previously identified by standard procedures. Sporulated oocysts each of type I, II and III were inoculated separately into three groups of Wistar rats (n = 9) respectively. Two separate control groups received either phosphate buffered saline (PBS) or MK-801 (dizocilpine). Behaviour changes were evaluated at nine weeks post infection in a square box, elevated plus maze and gene expression level of DRD and IDO compounds. The study revealed increased fatal feline attraction, reduced anxiety, decreased DRD and increased IDO gene expression in the T. gondii infected groups and MK-801 compared to the PBS control group. In conclusion, T. gondii infection alter the level of neurotransmitters in rat which cause cognitive impairment. This implies that all the T. gondii strain can cause behaviour changes if human were infected. Elsevier 2023-03-09 /pmc/articles/PMC10025920/ /pubmed/36950587 http://dx.doi.org/10.1016/j.heliyon.2023.e14370 Text en © 2023 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Article Wana, Mohammed Nasiru Watanabe, Malaika Chiroma, Samaila Musa Unyah, Ngah Zasmy Abdullahi, Sharif Alhassan Nordin, Shariza Basir, Rusliza Mohd Moklas, Mohamad Aris Majid, Roslaini Abd Toxoplasma gondii induced cognitive impairment in rats via dysregulation of dopamine receptors and indoleamine 2,3 dioxygenase |
title | Toxoplasma gondii induced cognitive impairment in rats via dysregulation of dopamine receptors and indoleamine 2,3 dioxygenase |
title_full | Toxoplasma gondii induced cognitive impairment in rats via dysregulation of dopamine receptors and indoleamine 2,3 dioxygenase |
title_fullStr | Toxoplasma gondii induced cognitive impairment in rats via dysregulation of dopamine receptors and indoleamine 2,3 dioxygenase |
title_full_unstemmed | Toxoplasma gondii induced cognitive impairment in rats via dysregulation of dopamine receptors and indoleamine 2,3 dioxygenase |
title_short | Toxoplasma gondii induced cognitive impairment in rats via dysregulation of dopamine receptors and indoleamine 2,3 dioxygenase |
title_sort | toxoplasma gondii induced cognitive impairment in rats via dysregulation of dopamine receptors and indoleamine 2,3 dioxygenase |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025920/ https://www.ncbi.nlm.nih.gov/pubmed/36950587 http://dx.doi.org/10.1016/j.heliyon.2023.e14370 |
work_keys_str_mv | AT wanamohammednasiru toxoplasmagondiiinducedcognitiveimpairmentinratsviadysregulationofdopaminereceptorsandindoleamine23dioxygenase AT watanabemalaika toxoplasmagondiiinducedcognitiveimpairmentinratsviadysregulationofdopaminereceptorsandindoleamine23dioxygenase AT chiromasamailamusa toxoplasmagondiiinducedcognitiveimpairmentinratsviadysregulationofdopaminereceptorsandindoleamine23dioxygenase AT unyahngahzasmy toxoplasmagondiiinducedcognitiveimpairmentinratsviadysregulationofdopaminereceptorsandindoleamine23dioxygenase AT abdullahisharifalhassan toxoplasmagondiiinducedcognitiveimpairmentinratsviadysregulationofdopaminereceptorsandindoleamine23dioxygenase AT nordinshariza toxoplasmagondiiinducedcognitiveimpairmentinratsviadysregulationofdopaminereceptorsandindoleamine23dioxygenase AT basirrusliza toxoplasmagondiiinducedcognitiveimpairmentinratsviadysregulationofdopaminereceptorsandindoleamine23dioxygenase AT mohdmoklasmohamadaris toxoplasmagondiiinducedcognitiveimpairmentinratsviadysregulationofdopaminereceptorsandindoleamine23dioxygenase AT majidroslainiabd toxoplasmagondiiinducedcognitiveimpairmentinratsviadysregulationofdopaminereceptorsandindoleamine23dioxygenase |